Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Osteoblastic Activity With 18F-Fluoride in Aortic Bioprosthesis Structural Valve Dysfunction (SVD)

NCT03015818 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT03015818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03015818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Osteoblastic Activity With 18F-Fluoride in Aortic Bioprosthesis Structural Valve Dysfunction (SVD)
Lead sponsor
Nantes University Hospital
Phase
Phase 4
Overall status
Completed
Start date
January 30, 2017
Completion date
May 3, 2019
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic bioprosthesis structural valve dysfunction